Latest Articles
The Fragmented Nightmare of Modern Drug Discovery Ends Here. We've Been Building EMET for a Decade. Here It Is.
company
The Fragmented Nightmare of Modern Drug Discovery Ends Here. We've Been Building EMET for a Decade. Here It Is.
company
Scientific Integrity by Design: Engineering Disciplined AI for Preclinical R&D
insights
Trust in the Age of Modern AI: Why Design Principles Matter More Than Ever
insights
AI at BenchSci: What We Learned Building Real Impact in 2025
insights
What Does "Good” Look Like: Scaling Evaluation of Non-Deterministic GenAI Systems in Disease Biology Research
insights
BenchSci Extends ASCEND Agreement with Merck to Support Preclinical Disease Biology Research
press
Introducing LEAP: The Evidence-based AI engine for predicting novel biology and experimental design
insights
BenchSci Ranked Among Fastest-Growing Companies in North America on the 2025 Deloitte Technology Fast 500™
press
Collaboration aims to build AI systems capable of biological inference and experimental assay prediction.
updates